You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy

Article metrics

Article menu
XML
Immunotherapy biomarkers
Original research
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy

 

Online download statistics by month:

Online download statistics by month: December 2020 to July 2025

AbstractFullPdf
Dec 2020382382113
Jan 2021459459236
Feb 202115415460
Mar 202113213247
Apr 2021858551
May 2021949447
Jun 202110110138
Jul 2021777738
Aug 202110110156
Sep 2021111111102
Oct 2021149149128
Nov 2021138140116
Dec 202111811895
Jan 2022919349
Feb 2022687264
Mar 2022868746
Apr 2022808239
May 2022676739
Jun 2022717526
Jul 2022727423
Aug 2022707033
Sep 2022596139
Oct 2022737547
Nov 2022596035
Dec 2022686927
Jan 2023464622
Feb 2023636323
Mar 2023344025
Apr 2023262817
May 2023494924
Jun 2023454720
Jul 2023707424
Aug 2023202017
Sep 2023363717
Oct 2023434314
Nov 2023282916
Dec 2023484834
Jan 2024505129
Feb 2024707220
Mar 2024393947
Apr 2024414128
May 2024343621
Jun 2024464826
Jul 2024949539
Aug 202452568
Sep 2024394023
Oct 2024464628
Nov 2024424313
Dec 2024656519
Jan 2025525221
Feb 2025575726
Mar 2025393919
Apr 202510710728
May 2025646636
Jun 2025585826
Jul 2025110
Total446945242304